Tuesday, December 01, 2015 3:30:21 PM
So for less than half of what United Therapeutics received for their last Rare Pediatric Disease Priority Review Voucher they could buy up the entire float of Cellceutix. They have a pretty good idea of what that voucher is worth, I bet they might like to have another one to sell in the future. As a free bonus they could be a major share holder in a Company with, the first new class of antibiotic in the last 20 years that is about to begin a world wide Phase 3 trial, a possible treatment for Psoriasis that is wrapping up a phase 2 and is a pill not an injection and is way cheaper than biologics, then there is that Cancer/ oral mucositis drug that could be a blockbuster drug. I'll ignore the pre-clinical compounds (Autism drug etc.)
So if one entity controlled the entire float they could do something like this:
"The recent increase was after KaloBios CEO, Martin Shkreli, tweeted on November 26: “I spoke with my counsel & advisers and decided to stop lending my $KBIO shares out until I better understand the advantages of doing so.”
"Talk about a nightmare trade.
Joe Campbell had $37,000 in his online brokerage account when he went to bed on Wednesday night. By the time he woke up, not only had all that money vanished, but the amateur trader actually owed ETrade more than $100,000.
No, Campbell wasn't the victim of evil hackers. He was the victim of poor judgment -- and his ordeal should serve as a lesson for all investors.
Campbell was in such a desperate spot that he even set up a GoFundMe campaign begging for help. The effort eventually raised more than $5,000, though Campbell also took flak.
According to his GoFundMe page, Campbell placed a risky bet on Wednesday against KaloBio, (KBIO) a little known pharmaceutical company that was trading at $2. Campbell was basically betting that the stock would fall further.
Big bet backfires
When a friend who knew about his bet called the next morning to ask if he was okay, Campbell said his "heart dropped." He feared all $37,000 in his account might have been lost.
Reality was far worse. KaloBios shares had surged to $16 after the controversial former hedge fund manager Martin Shkreli had bought a stake. ETrade (ETFC) said not only had the account gone to zero, but he was on the hook for $106,445.56.
"Never in my wildest dreams did I imagine Etrade would NOT have some sort of stop or circuit breaker in place," Campbell wrote, adding that he was upset the online brokerage didn't notify him.
So-called "short" bets are always risky because in theory there is no limit to potential losses if the stock goes the other way. This trade was even more dangerous because Campbell held the position overnight, when he couldn't have done anything if the stock moved up. Plus, KaloBios is a tiny stock, making it susceptible to violent moves, in both directions. "
http://money.cnn.com/2015/11/20/investing/trader-gofundme-drug-kalobios-shkreli/
Put that under your pillow and sleep tight those of you holding the nearly 1 million (legal shorts). No thanks!
LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM